CRISPR Progress and Psychedelics in Spotlight Amid Biotech Surge | Science-Environment

CRISPR Progress and Psychedelics in Spotlight Amid Biotech Surge | Science-Environment

CRISPR Progress and Psychedelics in Spotlight Amid Biotech Surge In a significant move, Gerresheimer, a German medical packaging maker, has rebuffed a takeover attempt by U.S. firm Silgan. Sources intimate that talks have ceased for now.Meanwhile, scientists advancing a modified CRISPR gene-editing tool show promise in potentially neutralizing the extra chromosome causing Down syndrome.In the biotech space, notable Nasdaq debuts include Alamar B…

Researchers eye potential Down syndrome fix via advanced gene editing

Researchers have developed a modified version of the CRISPR gene-editing tool that ‌in early laboratory experiments suggests it may have the potential to "silence" the extra chromosome that causes Down syndrome.People with Down syndrome are born with an extra copy of chromosome 21, giving them 47 chromosomes instead of the usual 46."Because of this extra copy, many genes are disrupted and contribute to the cognitive impairment and early-onset Al…

Scientists use CRISPR to remove the extra chromosome in Down syndrome cells

Two separate research teams have published work suggesting that the era of doing nothing about the extra chromosome itself may be approaching its end.